Literature DB >> 6812674

Fibrin, red cell and platelet interactions in an experimental model of thrombosis.

J R Smith, A M White.   

Abstract

1 Insertion of a cotton thread into an arteriovenous shunt of an anaesthetized rat causes an increase in the weight of the thread due to deposition of thrombus. 2 The thrombus formed was of the venous (red) type, being sensitive to heparin, yet possessed important characteristics of an arterial thrombus, in that it was dependent on platelets and on rate of blood flow. 3 Thromboxane synthetase inhibitors had no effect on thrombus deposition. 4 Cyclo-oxygenase inhibitors did not significantly depress thrombus formation at doses which inhibited platelet function ex vivo. 5 Compounds which can modify the release or action of adenosine 5' -diphosphate partly inhibited thrombus formation. 6 A depression in clotting factor levels induced by sodium warfarin led to a highly significant reduction in thrombus formation at doses which caused a prolongation of prothrombin clotting time.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6812674      PMCID: PMC2044652          DOI: 10.1111/j.1476-5381.1982.tb09265.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  13 in total

1.  Persistence of thromboxane A2-like material and platelet release-inducing activity in plasma.

Authors:  J B Smith; C Ingerman; M J Silver
Journal:  J Clin Invest       Date:  1976-11       Impact factor: 14.808

2.  Thromboxanes: selective biosynthesis and distinct biological properties.

Authors:  P Needleman; M Minkes; A Raz
Journal:  Science       Date:  1976-07-09       Impact factor: 47.728

3.  The role of blood flow in platelet adhesion, fibrin deposition, and formation of mural thrombi.

Authors:  H R Baumgartner
Journal:  Microvasc Res       Date:  1973-03       Impact factor: 3.514

4.  On the inhibitory potency of imidazole and its derivatives on thromboxane synthetase.

Authors:  H H Tai; B Yuan
Journal:  Biochem Biophys Res Commun       Date:  1978-01-13       Impact factor: 3.575

5.  Inhibition by a stable analogue of adenosine triphosphate of platelet aggregation by adenosine diphosphate.

Authors:  G V Born; J G Foulks
Journal:  Br J Pharmacol       Date:  1977-09       Impact factor: 8.739

6.  Selective inhibition of prostaglandin endoperoxide thromboxane isomerase by 1-carboxyalkylimidazoles.

Authors:  T Yoshimoto; S Yamamoto; O Hayaishi
Journal:  Prostaglandins       Date:  1978-10

7.  Inhibition of platelet thrombus formation by chlorpromazine acting to diminish haemolysis.

Authors:  G V Born; A Wehmeier
Journal:  Nature       Date:  1979-11-08       Impact factor: 49.962

8.  Effect of 1-methyl-2-mercapto-5-(3-pyridyl)-imidazole (KC-6141), an anti-aggregating compound, on experimental thrombosis in rats.

Authors:  T Umetsu; K Sanai
Journal:  Thromb Haemost       Date:  1978-02-28       Impact factor: 5.249

9.  Inhibition of ADP-induced aggregation of human platelets by beta, gamma-methylene-ATP.

Authors:  P M Evans
Journal:  Cytobios       Date:  1978

10.  Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.

Authors:  M Hamberg; J Svensson; B Samuelsson
Journal:  Proc Natl Acad Sci U S A       Date:  1975-08       Impact factor: 11.205

View more
  6 in total

1.  Improved Stability of Proline-Derived Direct Thrombin Inhibitors through Hydroxyl to Heterocycle Replacement.

Authors:  Harry R Chobanian; Barbara Pio; Yan Guo; Hong Shen; Mark A Huffman; Maria Madeira; Gino Salituro; Jenna L Terebetski; James Ormes; Nina Jochnowitz; Lizbeth Hoos; Yuchen Zhou; Dale Lewis; Brian Hawes; Lyndon Mitnaul; Kim O'Neill; Kenneth Ellsworth; Liangsu Wang; Tesfaye Biftu; Joseph L Duffy
Journal:  ACS Med Chem Lett       Date:  2015-03-13       Impact factor: 4.345

2.  Quantified coronary frequency domain optical coherence tomography signal analysis for the evaluation of erythrocyte-rich thrombus: ex-vivo validation study.

Authors:  Yoshitaka Shiratori; Masato Watanabe; Nobuaki Suzuki; Toshio Fukusato; Ken Kozuma
Journal:  Int J Cardiovasc Imaging       Date:  2016-12-26       Impact factor: 2.357

3.  Hirudin: Its Biology and Clinical Use.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1994       Impact factor: 2.300

4.  Perioperative Transfusions and Venous Thromboembolism.

Authors:  Ruchika Goel; Cassandra D Josephson; Eshan U Patel; Molly R Petersen; Sarah Makhani; Steven M Frank; Paul M Ness; Evan M Bloch; Eric A Gehrie; Parvez M Lokhandwala; Marianne M Nellis; Oliver Karam; Beth H Shaz; Ravi M Patel; Aaron A R Tobian
Journal:  Pediatrics       Date:  2020-03-20       Impact factor: 7.124

5.  CGS 12970: a novel, long acting thromboxane synthetase inhibitor.

Authors:  J Ambler; K D Butler; E C Ku; E D Maguire; J R Smith; R B Wallis
Journal:  Br J Pharmacol       Date:  1985-10       Impact factor: 8.739

6.  The effect of synthetic ovarian hormones on an in vivo model of thrombosis in the rat.

Authors:  H Emms; G P Lewis
Journal:  Br J Pharmacol       Date:  1985-01       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.